Evidence map›Paper›PMID 36985691›Full record

ArticleMolecules (Basel, Switzerland)2023

A Novel Drug with Potential to Treat Hyperbilirubinemia and Prevent Liver Damage Induced by Hyperbilirubinemia: Carbon Dots Derived from

Rui Chen, Huagen Ma, Xiaopeng Li, Meijun Wang, Yunbo Yang, Tong Wu, Yue Zhang, Hui Kong, Huihua Qu, Yan Zhao

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Hepatoprotective Effect ofFood science & nutrition · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rui ChenSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Huagen MaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Xiaopeng LiSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Meijun WangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Yunbo YangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Tong WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
Yue ZhangSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Hui KongSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Huihua QuCenter of Scientific Experiment, Beijing University of Chinese Medicine, Beijing 100029, China.
Yan ZhaoSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Beijing University of Chinese Medicine · CN

Funding

Special Funds for Fundamental Research Expenses of the Central Universities (China) 2019-JYB-TD-001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PlatycodonQuantum DotsAnimalsBilirubinCarbonHydrogen PeroxideHyperbilirubinemiaLiverMiceBilirubinCarbonHydrogen Peroxidecarbon dotsdrug therapyhyperbilirubinemialiver protectionPlatycodon grandiflorum

Identifiers

PMID36985691
PMCPMC10056707
OpenAlexW4327729521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.